Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
723 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in KínaAI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis
- Where
- Anyang, Hangzhou, Shanghai
- Életkor
- 18 év to 75 év
- People
- 542
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07782294 - No phaseTaking peopleFluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer(IDEAL Stage 2b)
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 312
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT06788548 - Korai 1. fázisTaking peopleA IIT Study of 177Lu-DOTA-SNA040
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- SmartNuclide Biopharma
See details and how to joinNCT07595237 - 2. fázisNot yet taking people in KínaStudy of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer
- Where
- Putian
- Életkor
- 18 év to 80 év
- People
- 31
- Run by
- The Affiliated Hospital of Putian University
See details and how to joinNCT07780721 - No phaseCsak meghívásosNon-surgical Management After NIT for dMMR/MSI-H GC
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 12
- Run by
- Yong Zhou
See details and how to joinNCT07646574 - 2. fázisTaking peopleSafety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 86
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06826079 - No phaseTaking peopleReal-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China
- Where
- Beijing, Changchun, Changzhi, Fuzhou, Guangzhou, Haikou, Hangzhou, Hefei, Jiangmen, Nanjing, Shanghai, Shantou, Shenyang, Taiyuan, Taizhou, Tianjin, Xiamen, Xi'an, Xuzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 260
- Run by
- Daiichi Sankyo
See details and how to joinNCT06846996 - 1/2. fázisTaking peopleIBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 55
- Run by
- Ruijin Hospital
See details and how to joinNCT07025889 - No phaseNot yet taking people in KínaStandardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma
- Where
- Chengdu, Guangzhou, Kunming, Shanghai, Tianjin, Zhengzhou
- Életkor
- 18 év to 80 év
- People
- 500
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07769658 - No phaseNot yet taking people in KínaRetlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 68
- Run by
- RenJi Hospital
See details and how to joinNCT07769866 - 2. fázisTaking peopleA Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer
- Where
- Zhengzhou
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07770113 - 2. fázisNot yet taking people in KínaAn Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 92
- Run by
- Tan Lijie
See details and how to joinNCT07770672 - No phaseTaking peopleFull-time RDI for ESD: Impact on Major Adverse Events and Procedure Time
- Where
- Xi’an
- Életkor
- 18 év to 75 év
- People
- 640
- Run by
- Xijing Hospital of Digestive Diseases
See details and how to joinNCT07401303 - 2/3. fázisTaking peopleNeoadjuvant and Adjuvant Therapy Studies of Sintilimab Combined With Chemotherapy With or Without Ipilimumab N01 in Resectable Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 720
- Run by
- Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07643623 - No phaseNot yet taking people in KínaHome-based Whole Course Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health
- Where
- Qingdao
- Életkor
- 18 év and over
- People
- 328
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT07764523 - 1. fázisTaking peopleA Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- Where
- Beijing, Changsha, Chongqing, Heilongjiang, Shandong, Shanghai, Wuhan, Zhejiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- ArriVent BioPharma, Inc.
See details and how to joinNCT07066657 - No phaseTaking peopleLymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 212
- Run by
- Ruijin Hospital
See details and how to joinNCT06596954 - No phaseTaking peopleEvaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
- Where
- Dalian, Hami, Heze, Jinan, Langfang, Liu‘an, Qingdao, Wuhan, Wuwei, Wuxi, Xi'an, Zhaoqing
- Életkor
- 18 év and over
- People
- 5000
- Run by
- Xijing Hospital
See details and how to joinNCT07600125 - 2. fázisTaking peopleThe Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion Therapy
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 126
- Run by
- Fudan University
See details and how to joinNCT07757165 - 3. fázisTaking peopleStudy of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- Where
- Beijing, Changzhou, Fuzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou, Linyi, Meizhou, Shenyang, Suzhou, Taiyuan, Tianjin, Ürümqi, Wuhan, Wuxi, Xiamen, Xi'an, Xuhui District, Xuzhou, Yinchuan, Zhengzhou
- Életkor
- 18 év and over
- People
- 726 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06731478 - 2. fázisTaking peopleNeoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 51
- Run by
- Sun Yat-sen University
See details and how to joinNCT07751055 - No phaseTaking peopleA Randomized, Controlled, Open-Label, Multi-center Clinical Study Comparing the Efficacy of Close Follow-Up Versus Adjuvant Chemotherapy in Patients With Stage IB-IIA Gastric or Gastroesophageal Junction Adenocarcinoma Following Radical Surgery
- Where
- Xi'an
- Életkor
- 18 év and over
- People
- 500
- Run by
- Xijing Hospital
See details and how to joinNCT07751302 - 2. fázisTaking peoplePerioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 198
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06510010 - No phaseTaking peopleThe Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 4
- Run by
- yi shen
See details and how to joinNCT07596654 - 2. fázisTaking peopleAssessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
- Where
- Beijing, Chengdu, Harbin, Nanjing, Qingdao, Shijiazhuang, Taiyuan, Tianjin, Xi’an, Zhengzhou
- Életkor
- 18 év and over
- People
- 106
- Run by
- Peking University
See details and how to joinNCT07127822